相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer Chemotherapy With Lipid-Based Nanocarriers
Na Zhang et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis
Robert L. Yauch et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
Preparation of RGD-modified Long Circulating Liposome Loading Matrine, and its in vitro Anti-cancer Effects
Xiao-yan Liu et al.
International Journal of Medical Sciences (2012)
LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor
Zhiqiang Yan et al.
JOURNAL OF CONTROLLED RELEASE (2012)
PEGylated Liposomal Doxorubicin Targeted to α5β1-Expressing MDA-MB-231 Breast Cancer Cells
Kamlesh Shroff et al.
LANGMUIR (2012)
Targeting properties of peptide-modified radiolabeled liposomal nanoparticles
Anna Helbok et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Polymersomes functionalized via click chemistry with the fibronectin mimetic peptides PR_b and GRGDSP for targeted delivery to cells with different levels of α5β1 expression
Todd O. Pangburn et al.
SOFT MATTER (2012)
Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year
Marine Gross-Goupil et al.
CURRENT UROLOGY REPORTS (2012)
Peptide-labeled Supramolecular Aggregates as Selective Doxorubicin Carriers for Delivery to Tumor Cells
Anna Morisco et al.
BIOPOLYMERS (2011)
Nanomedicine in cancer therapy: Innovative trends and prospects
Elvin Blanco et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Pep-1 Peptide-Modified Liposomal Carriers for Intracellular Delivery of Gold Nanoparticles
Myung Joo Kang et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2011)
Target-Selective Drug Delivery through Liposomes Labeled with Oligobranched Neurotensin Peptides
Chiara Falciani et al.
CHEMMEDCHEM (2011)
Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors
Patricia M. LoRusso et al.
CLINICAL CANCER RESEARCH (2011)
pH-Sensitive PEGylated Liposomes Functionalized With a Fibronectin-Mimetic Peptide Show Enhanced Intracellular Delivery to Colon Cancer Cells
Ashish Garg et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
RGD-targeted paramagnetic liposomes for early detection of tumor: In vitro and in vivo studies
Wei Li et al.
EUROPEAN JOURNAL OF RADIOLOGY (2011)
Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature
Thomas P. Herringson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Delivery of Nanoparticle-complexed Drugs across the Vascular Endothelial Barrier via Caveolae
Zhenjia Wang et al.
IUBMB LIFE (2011)
Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors
Amanda Lowery et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating
Khalid Oumzil et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid
Thomas P. Herringson et al.
JOURNAL OF DRUG TARGETING (2011)
Truncated bFGF-Mediated Cationic Liposomal Paclitaxel for Tumor-Targeted Drug Delivery: Improved Pharmacokinetics and Biodistribution in Tumor-Bearing Mice
Xianhuo Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Heterogeneous Liposome Membranes with pH-Triggered Permeability Enhance the in Vitro Antitumor Activity of Folate-Receptor Targeted Liposomal Doxorubicin
Elina Marnasheva et al.
MOLECULAR PHARMACEUTICS (2011)
Targeted Delivery of Cargoes into a Murine Solid Tumor by a Cell-Penetrating Peptide and Cleavable Poly(ethylene glycol) Comodified Liposomal Delivery System via Systemic Administration
Rui Kuai et al.
MOLECULAR PHARMACEUTICS (2011)
Novel Tetrapeptide, RGDF, Mediated Tumor Specific Liposomal Doxorubicin (DOX) Preparations
Huirui Du et al.
MOLECULAR PHARMACEUTICS (2011)
A Novel Peptide Probe for Imaging and Targeted Delivery of Liposomal Doxorubicin to Lung Tumor
Xiaofeng He et al.
MOLECULAR PHARMACEUTICS (2011)
Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies
Tore-Geir Iversen et al.
NANO TODAY (2011)
LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics
Zhiqiang Yan et al.
NANOTECHNOLOGY (2011)
Targeting kidney mesangium by nanoparticles of defined size
Chung Hang J. Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
Dimitrios Iliopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
More Effective Nanomedicines through Particle Design
Jin Wang et al.
SMALL (2011)
A novel DDS strategy, dual-targeting, and its application for antineovascular therapy
Yuki Murase et al.
CANCER LETTERS (2010)
Combined Delivery and Magnetic Resonance Imaging of Neural Cell Adhesion Molecule-Targeted Doxorubicin-Containing Liposomes in Experimentally Induced Kaposi's Sarcoma
Cristina Grange et al.
CANCER RESEARCH (2010)
Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies
Yi-fei Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin
Juan Jiang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Tumor targeting of functionalized lipid nanoparticles: Assessment by in vivo fluorescence imaging
Mathieu Goutayer et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78
Yasufumi Katanasaka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake
Kazuhiro Takara et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Targeting of drugs and nanoparticles to tumors
Erkki Ruoslahti et al.
JOURNAL OF CELL BIOLOGY (2010)
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome
Ayele H. Negussie et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide
Xiang Chen et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
Monica Loi et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Endocytosis of nanomedicines
Gaurav Sahay et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Liposomes modified with YIGSR peptide for tumor targeting
Praveen K. Dubey et al.
JOURNAL OF DRUG TARGETING (2010)
PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells
Wenbing Dai et al.
JOURNAL OF DRUG TARGETING (2010)
Lipid-based nanotherapeutics for siRNA delivery
A. Schroeder et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin
M. P. Rivera-Fillat et al.
JOURNAL OF PEPTIDE SCIENCE (2010)
Peptide modified nanocarriers for selective targeting of bombesin receptors
Antonella Accardo et al.
MOLECULAR BIOSYSTEMS (2010)
Binding of the Fibronectin-Mimetic Peptide, PR_b, to α5β1 on Pig Islet Cells Increases Fibronectin Production and Facilitates Internalization of PR_b Functionalized Liposomes
Nicole A. Atchison et al.
LANGMUIR (2010)
Efficient Delivery of Payload into Tumor Cells in a Controlled Manner by TAT and Thiolytic Cleavable PEG Co-Modified Liposomes
Rui Kuai et al.
MOLECULAR PHARMACEUTICS (2010)
Cytoplasmic Delivery of Liposomes into MCF-7 Breast Cancer Cells Mediated by Cell-Specific Phage Fusion Coat Protein
Tao Wang et al.
MOLECULAR PHARMACEUTICS (2010)
Internalization of p5314-29 Peptide Amphiphiles and Subsequent Endosomal Disruption Results in SJSA-1 Cell Death
Dimitris Missirlis et al.
MOLECULAR PHARMACEUTICS (2010)
A Novel Octreotide Modified Lipid Vesicle Improved the Anticancer Efficacy of Doxorubicin in Somatostatin Receptor 2 Positive Tumor Models
Junlin Zhang et al.
MOLECULAR PHARMACEUTICS (2010)
Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein
Tao Wang et al.
NANOMEDICINE (2010)
Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency
Prashanth K. Jayanna et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes
Shuyan Meng et al.
NANOTECHNOLOGY (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Cooperative nanomaterial system to sensitize, target, and treat tumors
Ji-Ho Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots
Willem J. M. Mulder et al.
ANGIOGENESIS (2009)
Nanocarriers' entry into the cell: relevance to drug delivery
Herve Hillaireau et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo
Shuxian Song et al.
FASEB JOURNAL (2009)
Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide
Ashish Garg et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors
De-Kuan Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Peptide- and Aptamer-Functionalized Nanovectors for Targeted Delivery of Therapeutics
Todd O. Pangburn et al.
JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME (2009)
A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells
Junhua Mai et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules
Thomas P. Herringson et al.
JOURNAL OF CONTROLLED RELEASE (2009)
RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer
Hui Zhao et al.
JOURNAL OF DRUG TARGETING (2009)
A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer
De-Kuan Chang et al.
PLOS ONE (2009)
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements
Thomas Schluep et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PR_b-targeted delivery of tumor necrosis factor-alpha by polymersomes for the treatment of prostate cancer
Doene Demirgoez et al.
SOFT MATTER (2009)
Targeted Tumor Diagnosis and Therapy with Peptide Hormones as Radiopharmaceuticals
Annette Beck-Sickinger et al.
Anti-Cancer Agents in Medicinal Chemistry (2008)
Anti body-targeted liposomes in cancer therapy and imaging
Stavroula Sofou et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Somatostatin, cortistatin and their receptors in tumours
M. Volante et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells
Jenilyn J. Virrey et al.
MOLECULAR CANCER RESEARCH (2008)
PR_b-Targeted PEGylated Liposomes for Prostate Cancer Therapy
Doene Demirgoez et al.
LANGMUIR (2008)
Noninvasive assessment of cancer response to therapy
Zhaozhong Han et al.
NATURE MEDICINE (2008)
Nanoparticle-mediated cellular response is size-dependent
Wen Jiang et al.
NATURE NANOTECHNOLOGY (2008)
Sheddable coatings for long-circulating nanoparticles
Birgit Romberg et al.
PHARMACEUTICAL RESEARCH (2008)
Targeting the neural cell adhesion molecule in cancer
Markus Jensen et al.
CANCER LETTERS (2007)
Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles
J. E. Schroeder et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Renal clearance of quantum dots
Hak Soo Choi et al.
NATURE BIOTECHNOLOGY (2007)
Endocytic mechanisms for targeted drug delivery
Lisa A. Bareford et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Solid lipid nanoparticles as a drug delivery system for peptides and proteins
Antonio J. Almeida et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
H. Hatakeyama et al.
GENE THERAPY (2007)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
Self-assembly and applications of biomimetic and bioactive peptide-amphiphiles
Efrosini Kokkoli et al.
SOFT MATTER (2006)
Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells
Takeshi Terada et al.
JOURNAL OF DRUG TARGETING (2006)
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo
Parisa Khalili et al.
MOLECULAR CANCER THERAPEUTICS (2006)
GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development
Shengzhan Luo et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Design of a novel fibronectin-mimetic peptide-amphiphile for functionalized biomaterials
A Mardilovich et al.
LANGMUIR (2006)
Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe
WJM Mulder et al.
NANO LETTERS (2006)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Lymphangiogenesis in development and human disease
K Alitalo et al.
NATURE (2005)
Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes
CJ Smith et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Binding of activated α2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK
UK Misra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Tat peptide-mediated cellular delivery:: back to basics
H Brooks et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides
B Gupta et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor
R Tournaire et al.
EMBO REPORTS (2004)
Aminopeptidase A is a functional target in angiogenic blood vessels
S Marchiò et al.
CANCER CELL (2004)
Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles
RH Muller et al.
JOURNAL OF BIOTECHNOLOGY (2004)
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands
MA Arap et al.
CANCER CELL (2004)
Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells
YF Jia et al.
CANCER RESEARCH (2004)
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
P Laakkonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Review of epidermal growth factor receptor biology
RS Herbst
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Physico-chemical stability of colloidal lipid particles
B Heurtault et al.
BIOMATERIALS (2003)
Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: Evaluation in vitro and in vivo
CP Leamon et al.
BIOCONJUGATE CHEMISTRY (2003)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels
D Hallahan et al.
CANCER CELL (2003)
Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif
G Colombo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Anti-neovascular therapy using novel peptides homing to angiogenic vessels
N Oku et al.
ONCOGENE (2002)
Hypothalamic hormones and cancer
AV Schally et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2001)
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
VP Torchilin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The cell biology of thrombospondin-1
H Chen et al.
MATRIX BIOLOGY (2000)
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
R Binétruy-Tournaire et al.
EMBO JOURNAL (2000)
Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin
S Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)